Dr. Shahar Keinan is the co-founder and CEO of Polaris Quantum Biotech. She has over 20 years of extensive experience in the field of computational and theoretical chemistry and published over 50 peer-reviewed manuscripts in the fields of in-silico drug design and discovery, as well as molecular materials design and computational methods development. Shahar has received a Ph.D. in theoretical chemistry from The Hebrew University of Jerusalem, after which she moved to Northwestern University and Duke University for research positions. Previously she was CSO of Cloud Pharmaceuticals and has been instrumental in the development of the Quantum Molecular Design process since its inception at Duke University, and has pioneered the use of computational chemistry algorithms to optimize electro-optical materials and small molecule drugs.